Somasekar Seshagiri, PhDCEO and CSO at AntlerA Therapeutics
Sekar Seshagiri is leader in genomics and drug discovery. Prior to his current role as CEO and CSO of AntlerA, he spent over 20 years at Genentech where he was a Staff Scientist and Associate Director. During his tenure at Genentech, he established a state-of-the-art genomics laboratory where he conducted research in cancer and cell signaling areas to support drug discovery and development. He has authored and co-authored over 100 articles in peer-reviewed journals including Nature, Nature Genetics, Science, and Cancer Cell.